Cargando…
MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results
Autores principales: | Burnett, John C, McKie, Paul, Heublein, Denise, Huntley, Brenda, Chen, Horng, Cannone, Valentina, Buglioni, Alessia, McCormick, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565454/ http://dx.doi.org/10.1186/2050-6511-16-S1-A3 |
Ejemplares similares
-
Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension
por: Cannone, Valentina, et al.
Publicado: (2022) -
Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications
por: Chen, Yang, et al.
Publicado: (2018) -
CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart
por: Martin, Fernando L., et al.
Publicado: (2012) -
Signaling via guanylyl cyclase C: cGMP, Src and p21
por: Basu, Nirmalya, et al.
Publicado: (2011) -
Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases
por: Kopra, Kari, et al.
Publicado: (2020)